HEREDITARY ANEURYSM RISK

Hereditary Aneurysm Risk — aortic and cerebral aneurysm rupture is preventable through imaging surveillance and elective repair, but only when at-risk individuals are identified genetically before the first catastrophic event.

Whole genome sequencing evaluates all aneurysm predisposition genes — FBN1, TGFBR1/2, ACTA2, MYH11, SMAD3, COL3A1, PRKG1, FLNA — and connects to existing Marfan, Loeys-Dietz, and EDS pages for comprehensive vascular connective tissue evaluation.

ACTA2
FBN1
TGFBR1
TGFBR2
MYH11
SMAD3
COL3A1

About this condition

Aneurysm — Genetic Risk

Thoracic aortic aneurysm and dissection (TAAD) is a life-threatening condition — aortic dissection has approximately 40% prehospital mortality, meaning many patients die before reaching the operating room. Approximately 20% of TAAD is familial, with identified genetic causes in ~30% of familial cases. ACTA2 is the most common non-syndromic familial TAAD gene (~14% of familial cases), followed by MYH11, SMAD3, TGFBR1/2 (Loeys-Dietz), FBN1 (Marfan), and COL3A1 (vascular Ehlers-Danlos). Syndromic forms (Marfan, Loeys-Dietz, vascular EDS) have additional systemic features enabling clinical recognition, but non-syndromic TAAD is often clinically silent until dissection.

Gene-specific aortic surveillance guidelines determine imaging frequency and surgical thresholds. FBN1/Marfan: prophylactic aortic root replacement at 5.0 cm (or 4.5 cm with risk factors). TGFBR1/2/Loeys-Dietz: surgery at 4.0-4.2 cm (more aggressive due to higher rupture risk at smaller diameters). ACTA2: annual imaging with surgical intervention based on rate of growth. COL3A1/vascular EDS: arterial imaging with extreme caution (invasive angiography is contraindicated due to arterial fragility). These gene-specific thresholds prevent under- or over-treatment.

Cerebral (intracranial) aneurysms also have genetic predisposition — approximately 10-20% of cerebral aneurysm patients have a family history. Genes implicated include PCNT (pericentrin), SOX17, CDKN2A/B, EDNRA, and connective tissue disorder genes (COL3A1, FBN1). First-degree relatives of patients with ruptured cerebral aneurysm have a 4x increased risk and benefit from screening MRA. Some familial TAAD genes (ACTA2, TGFBR1/2) also confer cerebral aneurysm risk, requiring both aortic and cerebral imaging.

Aortic dissection has ~40% prehospital mortality — most patients die before reaching surgery. Genetic identification enables imaging surveillance that detects aneurysms BEFORE dissection, allowing planned elective repair instead of emergency surgery.

Gene locus: ACTA2 (10q23.31), FBN1 (15q21.1), TGFBR1 (9q22.33), TGFBR2 (3p24.1), MYH11 (16p13.11), SMAD3 (15q22.33), COL3A1 (2q32.2)

Aortic dissection kills before patients reach the hospital. The only prevention strategy is identifying at-risk individuals through genetic testing and screening them with imaging before the aneurysm ruptures.

Surgical thresholds differ by gene — Loeys-Dietz aortas dissect at smaller diameters than Marfan, requiring earlier surgery

Standard aortic guidelines recommend surgery at 5.5 cm for ascending aortic aneurysm. Marfan (FBN1) guidelines lower this to 5.0 cm. Loeys-Dietz (TGFBR1/2) lowers it further to 4.0-4.2 cm — because Loeys-Dietz aortas can dissect at diameters considered 'safe' by standard guidelines. Without molecular diagnosis, a Loeys-Dietz patient's 4.5 cm aorta may be 'watched' until it reaches 5.5 cm — by which time dissection may have already occurred. Molecular diagnosis enables gene-appropriate surgical timing.

ACTA2 causes more than aortic aneurysm — early-onset stroke, coronary disease, and Moyamoya are part of the ACTA2 vascular phenotype

ACTA2 R179H causes a distinctive variant with Moyamoya disease (cerebral arterial occlusion), early-onset coronary artery disease, and aortic disease. Other ACTA2 variants cause familial TAAD without these additional features. Molecular identification of the specific ACTA2 variant determines whether cerebrovascular and coronary surveillance is needed in addition to aortic imaging — a management distinction that changes the entire surveillance protocol.

Hereditary Aneurysm Risk — aortic and cerebral aneurysm rupture is preventable through imaging surveillance and elective repair, but only when at-risk individuals are identified genetically before the first catastrophic event.

Aneurysm — Genetic Risk

Aortic dissection kills before patients reach the hospital. The only prevention strategy is identifying at-risk individuals through genetic testing and screening them with imaging before the aneurysm ruptures.

Surgical thresholds differ by gene — Loeys-Dietz aortas dissect at smaller diameters than Marfan, requiring earlier surgery

ACTA2 causes more than aortic aneurysm — early-onset stroke, coronary disease, and Moyamoya are part of the ACTA2 vascular phenotype

Others in Cardiovascular

One test. A lifetime of answers.